News
UK Pharma Firm Wins US Backing For Antibody-Based COVID-19 Treatment
AstraZeneca has secured support from the US government to advance the development of antibody-based COVID-19 treatments as the British drugmaker ramps up efforts beyond its potential vaccine to combat the global health crisis.
The company said on Tuesday it had...
News
Novadoz Pharmaceuticals FDA Approvals of Oseltamivir and Dofetilide Continues the Company’s Rise in the Generic Market
Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, located in Hyderabad India, recently received FDA approval for their generic versions of Oseltamivir Phosphate Capsules and Dofetilide Capsules.
The company was notified earlier this year, that Dofetilide...
News
Jones Healthcare Group Invests in New High-Performance Uhlmann Blister Packaging Line
Jones Healthcare Group, a market leader in advanced packaging and medication dispensing solutions, announces a significant investment in its packaging services offering including a new, fully integrated two-lane Uhlmann blister packaging line. The highly automated equipment will enhance the...
News
US Govt. Invests $143M to Scale Up SiO2’s Primary Packaging Platform
SiO2 Materials Science, a privately-owned U.S. advanced materials science corporation introducing breakthrough disruptive technology for packaging biological pharmaceuticals and vaccines, has unveiled a $143 million agreement with the federal government.
The agreement with the Department of Defense’s Joint Program Executive...
News
Berkshire Sterile Manufacturing lands financing for major expansion
Berkshire Sterile Manufacturing took another step toward an ambitious $20 million expansion plan when it recently closed on the majority of the project’s financing.
The firm, which has been playing a role in developing medications used to treat patients with...
News
UCB Acquires Engage Therapeutics for $125M
UCB announced the acquisition of Engage Therapeutics, Inc., a clinical-stage pharmaceutical company developing Staccato®Alprazolam for the rapid termination of an active epileptic seizure, for US$ 125 million in cash (subject to certain adjustments) and up to US$ 145 million...
News
Lonza to Host New Webinar – “The Compendia are ready. Are you? A More Sustainable Future for Endotoxin Testing”
On 16 June, Lonza will host a free 60-minute webinar on the latest regulatory developments surrounding the use of the recombinant Factor C (rFC) assay for endotoxin detection in parenteral pharmaceuticals and implantable medical devices. During the webinar, Allen...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read